Novo Nordisk AS (NVO)
85.00
-18.44
(-17.83%)
USD |
NYSE |
Dec 20, 16:00
86.00
+1.00
(+1.18%)
Pre-Market: 20:00
Novo Nordisk Market Cap: 377.51B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascendis Pharma AS | 8.142B |
| Evaxion Biotech AS | 5.391M |
| Amgen Inc | 141.58B |
| Viking Therapeutics Inc | 4.708B |
| Akari Therapeutics PLC | 24.02M |
Market Cap Related Metrics
| PE Ratio | 27.54 |
| PS Ratio | 9.648 |
| PEG Ratio | 0.9791 |
| Price to Book Value | 20.91 |
| Price to Free Cash Flow | 38.64 |
| Price | 85.00 |
| Earnings Yield | 3.63% |
| PEGY Ratio | 0.9232 |
| Operating PE Ratio | 22.04 |
| Normalized PE Ratio | 27.54 |